These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 17269159

  • 1. The antibacterial drugs market.
    Kresse H, Belsey MJ, Rovini H.
    Nat Rev Drug Discov; 2007 Jan; 6(1):19-20. PubMed ID: 17269159
    [No Abstract] [Full Text] [Related]

  • 2. The urgent need for new antibacterial agents.
    Wise R, BSAC Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development.
    J Antimicrob Chemother; 2011 Sep; 66(9):1939-40. PubMed ID: 21700627
    [No Abstract] [Full Text] [Related]

  • 3. Antibiotics at the crossroads.
    Nathan C.
    Nature; 2004 Oct 21; 431(7011):899-902. PubMed ID: 15496893
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The antibiotic pipeline--challenges, costs, and values.
    Wenzel RP.
    N Engl J Med; 2004 Aug 05; 351(6):523-6. PubMed ID: 15295041
    [No Abstract] [Full Text] [Related]

  • 6. Antibacterial drug discovery: is it all downhill from here?
    Projan SJ, Shlaes DM.
    Clin Microbiol Infect; 2004 Nov 05; 10 Suppl 4():18-22. PubMed ID: 15522036
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monopoly pricing of an antibiotic subject to bacterial resistance.
    Herrmann M.
    J Health Econ; 2010 Jan 05; 29(1):137-50. PubMed ID: 20015559
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
    Thomson CJ, Power E, Ruebsamen-Waigmann H, Labischinski H.
    Curr Opin Microbiol; 2004 Oct 05; 7(5):445-50. PubMed ID: 15451498
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic development: a victim of market forces?
    Tillotson GS.
    IDrugs; 2008 May 05; 11(5):340-6. PubMed ID: 18465675
    [Abstract] [Full Text] [Related]

  • 14. Overcoming the challenges in the pharma/biotech industry.
    Graul AI, Prous JR.
    Drug News Perspect; 2007 May 05; 20(1):57-68. PubMed ID: 17332900
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The bacteria fight back.
    Taubes G.
    Science; 2008 Jul 18; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract] [Full Text] [Related]

  • 20. Drug companies snub antibiotics as pipeline threatens to run dry.
    Clarke T.
    Nature; 2003 Sep 18; 425(6955):225. PubMed ID: 13679874
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.